Literature DB >> 28424322

Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS): A Rare but Potentially Treatable Condition.

Michael Karass1, Emily Grossniklaus2, Talal Seoud3, Sanjay Jain4, Daniel A Goldstein2,5.   

Abstract

Kaposi sarcoma inflammatory cytokine syndrome (KICS) is a newly-described condition affecting individuals who are HIV-positive and are infected with human herpesvirus 8 (HHV-8). This is a syndrome that in some ways mimics severe sepsis with associated acute respiratory distress syndrome, possibly requiring a ventilator and vasopressor support. However, unlike severe sepsis, antibiotics provide no benefit. Management of KICS has not been fully elucidated because of its high mortality rate. However, the syndrome has been successfully treated in some cases with immunomodulatory therapy. It is crucial for oncologists to be able to recognize this syndrome and to institute the appropriate therapy. The Oncologist 2017;22:623-625. © AlphaMed Press 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28424322      PMCID: PMC5423516          DOI: 10.1634/theoncologist.2016-0237

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  13 in total

1.  An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

Authors:  Thomas S Uldrick; Victoria Wang; Deirdre O'Mahony; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Seth M Steinberg; Stefania Pittaluga; Irina Maric; Denise Whitby; Giovanna Tosato; Richard F Little; Robert Yarchoan
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

2.  Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Authors:  Douglas A Jabs; Mark L Van Natta; John H Kempen; Peter Reed Pavan; Jennifer I Lim; Robert L Murphy; Larry D Hubbard
Journal:  Am J Ophthalmol       Date:  2002-01       Impact factor: 5.258

Review 3.  Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment.

Authors:  Manisha Bhutani; Mark N Polizzotto; Thomas S Uldrick; Robert Yarchoan
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

4.  Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.

Authors:  Thomas S Uldrick; Mark N Polizzotto; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Denise Whitby; Victoria Wang; Stefania Pittaluga; Deirdre O'Mahony; Seth M Steinberg; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

5.  Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

Authors:  S J Brandt; D M Bodine; C E Dunbar; A W Nienhuis
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy.

Authors:  Guillaume Breton; Xavier Duval; Candice Estellat; Xavier Poaletti; Daniel Bonnet; David Mvondo Mvondo; Pascale Longuet; Catherine Leport; Jean-Louis Vildé
Journal:  Clin Infect Dis       Date:  2004-11-09       Impact factor: 9.079

7.  Immune reconstitution inflammatory syndrome: risk factors and treatment implications.

Authors:  Yukari C Manabe; James D Campbell; Emily Sydnor; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2007-12-01       Impact factor: 3.731

8.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

9.  Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.

Authors:  Mark N Polizzotto; Thomas S Uldrick; Duosha Hu; Robert Yarchoan
Journal:  Front Microbiol       Date:  2012-03-02       Impact factor: 5.640

10.  Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.

Authors:  I Ratnam; C Chiu; N-B Kandala; P J Easterbrook
Journal:  Clin Infect Dis       Date:  2005-12-28       Impact factor: 9.079

View more
  10 in total

Review 1.  Castleman disease.

Authors:  Antonino Carbone; Margaret Borok; Blossom Damania; Annunziata Gloghini; Mark N Polizzotto; Raj K Jayanthan; David C Fajgenbaum; Mark Bower
Journal:  Nat Rev Dis Primers       Date:  2021-11-25       Impact factor: 65.038

2.  Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review.

Authors:  Cristina Micali; Ylenia Russotto; Alessio Facciolà; Andrea Marino; Benedetto Maurizio Celesia; Eugenia Pistarà; Grazia Caci; Giuseppe Nunnari; Giovanni Francesco Pellicanò; Emmanuele Venanzi Rullo
Journal:  Infect Dis Rep       Date:  2022-03-25

3.  A Rare Case of the Newly Recognized Kaposi Sarcoma Herpesvirus-Associated Disease.

Authors:  Qunfang Li; Faria Ali; Vivek Kak; Richard Santos
Journal:  Cureus       Date:  2020-06-23

Review 4.  A Fatal Case of Kaposi Sarcoma Immune Reconstitution Syndrome (KS-IRIS) Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS) or Multicentric Castleman Disease (MCD): A Case Report and Review.

Authors:  Igor Dumic; Milan Radovanovic; Oladapo Igandan; Ivana Savic; Charles W Nordstrom; Djordje Jevtic; Anand Subramanian; Poornima Ramanan
Journal:  Am J Case Rep       Date:  2020-12-03

Review 5.  Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections.

Authors:  Kumari Asha; Neelam Sharma-Walia
Journal:  Front Cell Infect Microbiol       Date:  2021-03-19       Impact factor: 5.293

Review 6.  Immune Reconstitution Inflammatory Syndrome Associated Kaposi Sarcoma.

Authors:  Isabelle Poizot-Martin; Sylvie Brégigeon; Romain Palich; Anne-Geneviève Marcelin; Marc-Antoine Valantin; Caroline Solas; Marianne Veyri; Jean-Philippe Spano; Alain Makinson
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

7.  Molecular Mechanisms of Kaposi Sarcoma Development.

Authors:  Andy Karabajakian; Isabelle Ray-Coquard; Jean-Yves Blay
Journal:  Cancers (Basel)       Date:  2022-04-07       Impact factor: 6.575

8.  Disseminated Kaposi Sarcoma.

Authors:  Jin-Yuan Ma; Jia-Wei Liu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-20

9.  The Sub-Nuclear Localization of RNA-Binding Proteins in KSHV-Infected Cells.

Authors:  Ella Alkalay; Chen Gam Ze Letova Refael; Irit Shoval; Noa Kinor; Ronit Sarid; Yaron Shav-Tal
Journal:  Cells       Date:  2020-08-25       Impact factor: 6.600

10.  Admitted AIDS-associated Kaposi sarcoma patients: Indications for admission and predictors of mortality.

Authors:  Faheema Vally; Wencilaus Margret Pious Selvaraj; Owen Ngalamika
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.